Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary

  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights

• 4.  U.S. Frozen Tissues Samples Market Variables, Trends & Scope

  •         1. Market Lineage Outlook
            2. Penetration and Growth Prospect Mapping
            3. Industry Value Chain Analysis
            4. Cost Analysis Breakdown
            5. Technology Overview
            6. Regulatory Framework
                6.1. Reimbursement Framework
                6.2. Standards and Compliances

• 5.   Market Overview

  •     1. Market Dynamics
            1.1. Market Driver Analysis
                1.1.1. Increasing focus of Frozen Tissues Samples Companies on Brand Protection
                1.1.2. Untapped Opportunities in Emerging Regions
            1.2. Market Restraint Analysis
                1.2.1. High Cost Associated with Implementation of Predictive Analysis
            1.3. Industry Challenges
                1.3.1. Presence of Ambiguous Regulatory Framework

• 6.  U.S. Frozen Tissues Samples Market Analysis Tools

  •         1. Industry Analysis - Porter’s
                1.1. Supplier Power
                1.2. Buyer Power
                1.3. Substitution Threat
                1.4. Threat from New Entrants
                1.5. Competitive Rivalry
            2. Pestel Analysis
                2.1. Political Landscape
                2.2. Environmental Landscape
                2.3. Social Landscape
                2.4. Technology Landscape
                2.5. Legal Landscape
            3. Major Deals And Strategic Alliances Analysis
                3.1. Joint Ventures
                3.2. Mergers and Acquisitions
                3.3. Licensing and Partnership
                3.4. Technology Collaborations
                3.5. Strategic Divestments
            4. Market Entry Strategies
            5. Case Studies

• 7.  U.S. Frozen Tissues Samples Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)

  • 1. Frozen normal tissue samples
    2. Frozen diseased tissue samples
    3. Frozen tumor tissue samples
    4. Fresh Frozen tissue samples
    5. Formalin-fixed paraffin-embedded tissues

• 8.   U.S. Frozen Tissues Samples Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

  • 1. Cancer research
    2. Disease Diagnosis
    3. Morphological analysis

• 9.  U.S. Frozen Tissues Samples Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  • 1. Academic & Research Institutes
    2. Banks
    3. Hospitals & clinics
    4. Diagnostic Centers
    5. Forensic Laboratories
    6. Others

• 10.  Market Share Analysis and Competitive Landscape

  • 1. Global Landscape - Key Players, Revenue and Presence
    2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    3. Global Emerging Companies
    4. North America - Market Share Analysis and Key Regional Players
    5. Europe - Market Share Analysis and Key Regional Players
    6. Asia Pacific - Market Share Analysis and Key Regional Players
    7. Global Key Player - Growth Matrix

• 11.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •         1. ProteoGenex
                1.1. Company Overview
                1.2. Product Portfolio
                1.3. SWOT Analysis
                1.4. Financial Overview
                1.5. Strategic Overview
            2. Biochain
                2.1. Company Overview
                2.2. Product Portfolio
                2.3. SWOT Analysis
                2.4. Financial Overview
                2.5. Strategic Overview
            3. OriGene Technologies, Inc.
                3.1. Company Overview
                3.2. Product Portfolio
                3.3. SWOT Analysis
                3.4. Financial Overview
                3.5. Strategic Overview
            4. Leica Biosystems
                4.1. Company Overview
                4.2. Product Portfolio
                4.3. SWOT Analysis
                4.4. Financial Overview
                4.5. Strategic Overview
            5. ZenBio, Inc.
                5.1. Company Overview
                5.2. Product Portfolio
                5.3. SWOT Analysis
                5.4. Financial Overview
                5.5. Strategic Overview
            6. Geneticist Inc.
                6.1. Company Overview
                6.2. Product Portfolio
                6.3. SWOT Analysis
                6.4. Financial Overview
                6.5. Strategic Overview
            7. AMS Biotechnology (Europe) Limited
                7.1. Company Overview
                7.2. Product Portfolio
                7.3. SWOT Analysis
                7.4. Financial Overview
                7.5. Strategic Overview
            8. US Biolab Corporation, Inc.
                8.1. Company Overview
                8.2. Product Portfolio
                8.3. SWOT Analysis
                8.4. Financial Overview
                8.5. Strategic Overview

• 12.  Pre and Post COVID-19 Impact

  • 1. Positive influence on the healthcare industry
    2. The financial disruption of the manufacturing sector
    3. Impact of COVID-19 on emerging companies
    4. Significant mandates in the healthcare regulations initiated by administrations
    5. The overall economic slowdown of the developing and developed nations

• 13.  FutureWise SME Key Takeaway Points for Client

  • .